Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01574183 · ClinicalTrials.gov registry record · Phase 2
Vilazodone Treatment for Marijuana Dependence
A Phase 2 study of Marijuana Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT01574183 is a Phase 2 study of Marijuana Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 76 participants, roughly in line with the 80-participant average among 6 other Marijuana Dependence trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT01574183, a Phase 2 study of Marijuana Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
Marijuana is the most commonly used illicit drug, yet few clinical trials have evaluated pharmacotherapy treatments for marijuana dependence. This study will evaluate the efficacy of vilazodone for reducing marijuana use in marijuana-dependent adults. A contingency management intervention (CM)and motivational enhancement therapy (MET)will be incorporated to encourage study engagement and retention, and genomic DNA will be extracted to characterize subjects according to polymorphisms of genes potentially relevant to the activity of vilazodone. It is hypothesized that vilazodone combined with MET and CM will reduce the percent of marijuana-positive urine drug screen results in marijuana-dependent individuals as compared to a placebo treatment combined with MET and CM.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Vilazodone
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01574183
The ClinicalTrials.gov registry entry for NCT01574183 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 80-participant average among 6 other Marijuana Dependence trials with a reported enrollment target. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Marijuana Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01574183 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01574183 about?
NCT01574183 is a clinical study titled "Vilazodone Treatment for Marijuana Dependence". Marijuana is the most commonly used illicit drug, yet few clinical trials have evaluated pharmacotherapy treatments for marijuana dependence. This study will evaluate the efficacy of vilazodone for reducing marijuana use in marijuana-dependent adults. A contingency management intervention (CM)and mo...
What is the current status of trial NCT01574183?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 76 participants. The study started on 2012-08. Estimated completion is 2016-02.
What conditions does trial NCT01574183 study?
This clinical trial studies the following conditions: Marijuana Dependence.
What interventions are being tested in trial NCT01574183?
The interventions under investigation include: Placebo (DRUG), Vilazodone (DRUG).
Who is sponsoring clinical trial NCT01574183?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01574183 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marijuana Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
COMPLETED · Phase 2
-
Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal
COMPLETED · Phase 2
-
Effect of Oxytocin on Craving and Therapy Response
COMPLETED · NA
-
Buspirone Treatment for Marijuana Dependence
COMPLETED · Phase 4
-
Marijuana Treatment Project 4
COMPLETED · NA
-
Effect of Oxytocin on Stress in Marijuana Users
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.